Invention Grant
![Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives](/docs/US/2016-09-13/US09439901B2/abs.jpg.600x600.jpg)
- Patent Title: Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
-
Application No.: US14535556Application Date: 2014-11-07
-
Publication No.: US09439901B2Publication Date: 2016-09-13
- Inventor: Vincent Mascitti
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Lisa A. Samuels
- Main IPC: A61K31/357
- IPC: A61K31/357 ; A61K31/155 ; C07D493/08 ; A61K31/4985 ; A61K45/06
![Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives](/abs-image/US/2016/09/13/US09439901B2/abs.jpg.150x150.jpg)
Abstract:
Compounds of Formula (A) and (B) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by sodium-glucose transporter inhibitors (in particular, SGLT2 inhibitors).
Public/Granted literature
- US20150065512A1 DIOXA-BICYCLO[3.2.1]OCTANE-2,3,4-TRIOL DERIVATIVES Public/Granted day:2015-03-05
Information query
